+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Retinopathy Drug"

Diabetic Retinopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Retinopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
Proliferative Diabetic Retinopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Proliferative Diabetic Retinopathy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
From
Radiation Retinopathy - Epidemiology Forecast - 2032 - Product Thumbnail Image

Radiation Retinopathy - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Diabetic Retinopathy - Epidemiology Forecast to 2032 - Product Thumbnail Image

Diabetic Retinopathy - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
From
From
From
Diabetic Retinopathy - Epidemiology Forecast to 2029 - Product Thumbnail Image

Diabetic Retinopathy - Epidemiology Forecast to 2029

  • Report
  • August 2020
  • 48 Pages
  • Global
From
Diabetic Retinopathy - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Retinopathy - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 358 Pages
  • Global
From
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2020 - Product Thumbnail Image

Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 57 Pages
  • Global
From
Loading Indicator

The Retinopathy Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat diseases of the eye. Retinopathy drugs are used to treat diseases of the retina, such as age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa. These drugs can be administered orally, topically, or by injection. Commonly used retinopathy drugs include anti-VEGF agents, corticosteroids, and photodynamic therapy. The Retinopathy Drug market is highly competitive, with many companies developing and marketing drugs to treat retinopathy. Some of the major players in the market include Regeneron Pharmaceuticals, Novartis, Allergan, Roche, and Bayer. Show Less Read more